Highlights
Human papillomavirus vaccination prevents cervical cancer, but in Pakistan early roll-out shows uneven coverage driven by trust, stigma, and misinformation rather than supply alone.
Partnering with respected religious leaders and community health workers can legitimize vaccination as cancer prevention aligned with family and faith.
Proactive social listening and rapid rebuttals are needed to counter rumors before they spread on WhatsApp and other platforms.
Reaching out-of-school girls and poorer districts -- free at point of care and embedded in the national immunization program -- is essential for equity and public confidence.
Cervical cancer is among the most preventable types of cancer, yet it remains a major cause of mortality in low- and middle-income countries (LMICs). Globally, it accounts for more than 340,000 deaths each year, with nearly 90% occurring in LMICs []. In Pakistan, cervical cancer ranks among the most common cancers in women, with an estimated 4,762 new cases and 3,069 deaths annually []. Although the human papillomavirus (HPV) vaccine is a safe and effective means of prevention, uptake in South Asia remains dismally low. A 2024 meta-analysis reported average coverage across the region of only about 8%, with Pakistan at the lower end []. In this Commentary, we propose immediate, practical measures to build trust to improve HPV vaccination uptake among eligible adolescent girls (9–14 years) in Pakistan.
In September 2025, Pakistan launched its first nationwide HPV vaccination campaign, aiming to immunize 13 million girls aged 9–14 years, with training for nearly 50,000 health workers and with plans to integrate the vaccine into the Expanded Program on Immunization (EPI) []. This campaign represents a historic step and the beginning of a new era of immunization in Pakistan, one that extends beyond infancy to include adolescent girls. Yet its success is far from guaranteed. Early reports show uneven coverage and parental skepticism, including markedly low uptake even in cities such as Karachi, and shortfalls relative to initial provincial targets []. Overall success will depend not only on logistics and supply but also on how effectively the program navigates cultural sensitivities, religious discourse, the spread of misinformation, and the legacies of past vaccination efforts.
The novelty of this campaign lies in its focus on adolescent girls, a group rarely targeted in Pakistan’s immunization landscape. Unlike infant vaccines, HPV requires parental consent for older children and inevitably touches on issues of sexuality, morality, and cultural values. This increases the risk of parental hesitancy, particularly in contexts where sexual and reproductive health is taboo. At the same time, the campaign is unfolding against a fraught history of vaccination. Polio eradication efforts in Pakistan have faced decades of setbacks, marked by refusals, entrenched rumor networks, and targeted violence, including attacks on female polio vaccinators and their security escorts []. A past incident in 2011 in which a health campaign was co-opted for non-health purposes intensified public skepticism toward vaccination drives []. Such events continue to shape how communities perceive door-to-door health programs.
COVID-19 vaccination added new complications but also provided lessons. Surveys across Pakistan revealed early hesitancy driven by fears about safety, efficacy, misinformation, and conspiracy theories []. These concerns mirror those now emerging around HPV. Yet COVID-19 uptake eventually increased, in part due to mandates, visible endorsements from political and religious leaders, and widespread availability in public facilities. Notably, national religious authorities publicly declared COVID-19 vaccination permissible under Sharia, illustrating how religious guidance can unlock acceptance when biomedical messaging alone stalls. The lesson is clear: trust is fragile but can be rebuilt through deliberate community engagement.
HPV vaccination, however, introduces a new layer of complexity. Because HPV is sexually transmitted, the vaccine is vulnerable to stigma and misinterpretation. Parents may worry that vaccination tacitly condones premarital sexual activity or even jeopardizes fertility. A recent systematic review of studies in Muslim-majority countries, including Pakistan, found that HPV vaccine hesitancy is shaped not only by doubts about safety and necessity but also by religious objections and moral anxieties, including fears of infertility, sexual promiscuity, and the presence of ‘haram’ ingredients []. If presented narrowly as a tool against infection, the vaccine may be rejected on moral grounds; reframing it as a cancer prevention measure, however, situates it as an act of parental protection and a religious duty to preserve life.
Religious authority is therefore not a barrier but a resource. During both polio and COVID-19 campaigns, religious scholars and imams issued public statements affirming the permissibility of vaccination under Sharia law. In high-risk areas of Karachi, parents themselves recommended that trusted figures such as well-known doctors, religious leaders, and sports or media personalities should be engaged as advocates for vaccination []. For HPV, early and sustained engagement with religious leaders is essential, not as token endorsement but as genuine partnership in message development. This engagement must emphasize the alignment between HPV vaccination and religious values of safeguarding health and family.
The battle over trust will not be fought only in mosques or clinics but also on smartphones. Rumors about infertility, Western plots, and “haram ingredients” spread rapidly on WhatsApp and Facebook. Experience from polio programming shows that waiting for rumors to crest is costly; proactive social listening, rapid rebuttals, and feedback loops can protect credibility before narratives harden.
Equity is equally decisive. Until recently, HPV vaccines were available almost exclusively in urban private hospitals, reinforcing perceptions of elitism and inaccessibility. The national campaign seeks to change this, but structural challenges remain. Almost 50% of girls in the target age group in Pakistan are not enrolled in school, meaning school-based campaigns alone will not achieve universal coverage or increase vaccine uptake. Outreach to slums, rural districts, and marginalized populations in provinces such as Sindh and Khyber Pakhtunkhwa is critical. Pilot campaigns have attempted to include out-of-school girls through neighborhood vaccination sites, but these must be scaled and sustained beyond one-off drives. While the current campaign, supported by Gavi, WHO, UNICEF, and other partners, is providing the HPV vaccine free of charge, its sustainability beyond external funding is uncertain. Embedding HPV vaccination within the EPI as a routine, government-financed service will be essential to maintain universal access. Without this long-term commitment, the vaccine risks again being seen as an intervention for elites, undermining trust and legitimacy.
Several pathways could help Pakistan navigate this moment. The Lady Health Worker program is uniquely positioned to build confidence, as these women are trusted household-level providers. Their proximity to families allows them to address hesitancy in ways that distant officials cannot. Religious scholars should be embedded as co-developers of messaging, allowing imams to frame vaccination as an act of parental responsibility rather than moral threat. Behavioral nudges should be incorporated: a recent mobile-based audio drama campaign in Pakistan led to a 30% increase in full childhood immunization in target areas relative to comparison areas, demonstrating how culturally tailored digital tools can shift behavior []. Similar strategies, including text reminders, school events, peer testimonials, could help normalize HPV vaccination. Finally, the government must expand beyond schools and urban centers, ensuring outreach in informal settlements, rural districts, and disaster-affected areas.
Although Pakistan’s HPV rollout is unique in timing and scale, its challenges are not unique. Across LMICs, immunization is shaped not only by technical logistics but also by culture, religion, and trust. In sub-Saharan Africa, Latin America, and the Middle East, HPV campaigns face similar barriers of stigma, misinformation, and inequitable access. Pakistan’s campaign therefore carries lessons with resonance beyond its borders. If the program succeeds in normalizing HPV vaccination in a conservative context, it can provide an example for other countries confronting similar obstacles. If it falters, the consequences may extend beyond Pakistan, reinforcing skepticism in comparable settings.
Pakistan’s HPV vaccination campaign currently as it stands is both historic and fragile. Its outcome will depend as much on relationships of trust as on syringes and cold chains. By embedding the program within trusted community networks, reframing the vaccine as cancer prevention, drawing lessons from past vaccination efforts, and ensuring equitable access, Pakistan has the opportunity to show that even the most culturally sensitive vaccines can succeed in conservative, resource-limited contexts. As health professionals, researchers, and educators with ties to both Pakistan and its diaspora, we write with a shared conviction that the world should not only observe but learn, global immunization equity depends not just on delivering vaccines, but on delivering them with dignity and trust.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
The author(s) declared that financial support was received for this work and/or its publication. APCs for this article were provided by St. Elizabeth Youngstown Hospital, Youngstown, OH, United States.
Conflict of interest
The authors declare that they do not have any conflicts of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
References
1.
HeWQLiC. Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends. Gynecol Oncol (2021) 163(3):583–92. 10.1016/j.ygyno.2021.10.075
2.
Cancer Today (2025). Available online at: https://gco.iarc.who.int/today/ (Accessed September 25, 2025).
3.
NoreenKNaeem KhalidSMuradMABaigMKhanSA. Uptake and determinants of HPV vaccination in south Asia: a systematic review and meta-analysis. Front Public Health (2024) 12:1453704. 10.3389/fpubh.2024.1453704
4.
WHO EMRO. WHO training 49,000 health workers for Pakistan’s first HPV drive to protect 13 million girls from cervical cancer (2025). Available online at: https://www.emro.who.int/pak/pakistan-news/who-training-49-000-health-workers-for-pakistans-first-hpv-drive-to-protect-13-million-girls-from-cervical-cancer.html (Accessed September 25, 2025).
5.
Only 34pc of HPV Vaccination Target Achieved as Drive Nears End - Pakistan - DAWN.COM. Karachi: DAWN (2025). Available online at: https://www.dawn.com/news/1944376 (Accessed September 25, 2025).
6.
AbbasiFHShaikhAAMehrajJRazaSMRasoolSBulloUFet alVaccine hesitancy and perceptions of the community about polio in high-risk areas of Karachi, Sindh, Pakistan. Vaccines (2023) 11(1):70. 10.3390/vaccines11010070
7.
Fake CIA Vaccine Campaign: When the end doesn’t justify the means. Smart Global Health. Washington, DC: CSIS. (2025). Available online at: https://www.csis.org/blogs/smart-global-health/fake-cia-vaccine-campaign-when-end-doesnt-justify-means (Accessed September 25, 2025).
8.
KhanMS. Improving the Covid-19 vaccination rate in Pakistan—A multipronged Policy approach. Front Public Health (2021) 9:729102. 10.3389/fpubh.2021.729102
9.
KisaSKisaA. Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: a scoping review. PLOS ONE (2024) 19(8):e0309597. 10.1371/journal.pone.0309597
10.
MunirSSaidFTajUZafarM. Digital “nudges” to increase childhood vaccination compliance: evidence from Pakistan. arXIV (2025). 10.48550/arXiv.2209.06624
Summary
Keywords
HPV vaccination, vaccine hesitancy, trust and culture, policy, Pakistan public health
Citation
Mir U, Asghar M, Amjad N, Amjad U, Khan I, Kifayat S, Kifayat S, Khan MAJ, Kobra KT, Wali Z, Wali B, Shafiq S, Ullah A, Jamil F, Ittefaq M and Khan MS (2026) Pakistan’s HPV vaccination drive: navigating trust, culture, and misinformation in a new era of immunization. Int. J. Public Health 71:1609244. doi: 10.3389/ijph.2026.1609244
Received
27 October 2025
Revised
03 November 2025
Accepted
02 June 2026
Published
11 June 2026
Volume
71 - 2026
Edited by
Lyda Osorio, University of the Valley, Colombia
Updates
Copyright
© 2026 Mir, Asghar, Amjad, Amjad, Khan, Kifayat, Kifayat, Khan, Kobra, Wali, Wali, Shafiq, Ullah, Jamil, Ittefaq and Khan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Umaima Mir, umaimamir029@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.